IL278401A - Polynucleotides for rna editing and methods of using same - Google Patents

Polynucleotides for rna editing and methods of using same

Info

Publication number
IL278401A
IL278401A IL278401A IL27840120A IL278401A IL 278401 A IL278401 A IL 278401A IL 278401 A IL278401 A IL 278401A IL 27840120 A IL27840120 A IL 27840120A IL 278401 A IL278401 A IL 278401A
Authority
IL
Israel
Prior art keywords
polynucleotides
methods
same
rna editing
editing
Prior art date
Application number
IL278401A
Other languages
Hebrew (he)
Inventor
Schwartz Schraga
NIR Ronit
Uzonyi Anna
Original Assignee
Yeda Res & Dev
Schwartz Schraga
NIR Ronit
Uzonyi Anna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Schwartz Schraga, NIR Ronit, Uzonyi Anna filed Critical Yeda Res & Dev
Priority to IL278401A priority Critical patent/IL278401A/en
Priority to PCT/IL2021/051281 priority patent/WO2022091100A1/en
Publication of IL278401A publication Critical patent/IL278401A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL278401A 2020-10-29 2020-10-29 Polynucleotides for rna editing and methods of using same IL278401A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL278401A IL278401A (en) 2020-10-29 2020-10-29 Polynucleotides for rna editing and methods of using same
PCT/IL2021/051281 WO2022091100A1 (en) 2020-10-29 2021-10-28 Polynucleotides for rna editing and methods of using same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL278401A IL278401A (en) 2020-10-29 2020-10-29 Polynucleotides for rna editing and methods of using same

Publications (1)

Publication Number Publication Date
IL278401A true IL278401A (en) 2022-05-01

Family

ID=79269784

Family Applications (1)

Application Number Title Priority Date Filing Date
IL278401A IL278401A (en) 2020-10-29 2020-10-29 Polynucleotides for rna editing and methods of using same

Country Status (2)

Country Link
IL (1) IL278401A (en)
WO (1) WO2022091100A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3475424A1 (en) 2016-06-22 2019-05-01 ProQR Therapeutics II B.V. Single-stranded rna-editing oligonucleotides
NZ751483A (en) 2016-09-01 2022-07-01 Proqr Therapeutics Ii Bv Chemically modified single-stranded rna-editing oligonucleotides
GB201808146D0 (en) 2018-05-18 2018-07-11 Proqr Therapeutics Ii Bv Stereospecific Linkages in RNA Editing Oligonucleotides
EP4652274A1 (en) 2023-01-18 2025-11-26 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Antisense oligonucleotides for rna editing and methods for using the same
CN118853661A (en) * 2023-04-28 2024-10-29 时夕(广州)生物科技有限公司 Methods, compositions and uses of editing RNA
WO2025231085A1 (en) * 2024-04-30 2025-11-06 Airna Corporation Site-directed editing of rna

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (en) 1971-02-10 1977-09-15 Organon Nv METHOD FOR THE DETERMINATION AND DETERMINATION OF SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES.
NL154598B (en) 1970-11-10 1977-09-15 Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING LOW MOLECULAR COMPOUNDS AND PROTEINS THAT CAN SPECIFICALLY BIND THESE COMPOUNDS AND TEST PACKAGING.
NL154599B (en) 1970-12-28 1977-09-15 Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES, AND TEST PACKAGING.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (en) 1972-05-11 1983-06-01 Akzo Nv METHOD FOR DETERMINING AND DETERMINING BITES AND TEST PACKAGING.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
DE122007000007I1 (en) 1986-04-09 2007-05-16 Genzyme Corp Genetically transformed animals secreting a desired protein in milk
US4873316A (en) 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US5541110A (en) 1994-05-17 1996-07-30 Bristol-Myers Squibb Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
DE102015012522B3 (en) 2015-09-26 2016-06-02 Eberhard Karls Universität Tübingen Methods and substances for directed RNA editing
EP3475424A1 (en) * 2016-06-22 2019-05-01 ProQR Therapeutics II B.V. Single-stranded rna-editing oligonucleotides
JP7347830B2 (en) 2018-06-29 2023-09-20 エバーハルト カール ウニヴェルジテート テュービンゲン Artificial nucleic acids for RNA editing
JP7252328B2 (en) 2018-10-12 2023-04-04 北京大学 Methods and compositions for editing RNA

Also Published As

Publication number Publication date
WO2022091100A1 (en) 2022-05-05

Similar Documents

Publication Publication Date Title
IL278401A (en) Polynucleotides for rna editing and methods of using same
GB2612212B (en) Compositions and methods for gene editing
EP4177345A4 (en) Improved rna editing method
GB202311318D0 (en) Compositions and methods for epigenetic editing
IL286324A (en) Methods and preparations for editing nucleotide sequences
IL273817A (en) Compositions and methods for editing rna
GB201905732D0 (en) RNA editing inhibitors and methods of use
EP3382018A4 (en) DNA METHYLATION EDITION KIT AND METHOD FOR EDITING DNA METHYLATION
CA3262119A1 (en) Oligonucleotides for adar-mediated rna editing and use thereof
CA3262406A1 (en) Gene editing components, systems, and methods of use
EP4251770A4 (en) Methods and compositions for sequencing complementary polynucleotides
IL288707A (en) Methods of using rad51 inhibitors for treatment of pancreatic cancer
GB201907733D0 (en) Methods and compositions for multiplex gene editing
IL311101A (en) Rna editing via recruitment of spliceosome components
IL290572A (en) Methods and compositions for dna base editing
IL312508A (en) Polynucleotides, compositions, and methods for genome editing
IL320277A (en) Compositions and methods comprising programmable snrnas for rna editing
SG10201906239RA (en) Compositions and methods for inhibition of rna editing for treatment of cancer
EP3987024A4 (en) COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITING
GB202113933D0 (en) Methods for gene editing
IL317701A (en) Compositions and methods for epigenetic editing
GB202214015D0 (en) RNA editing vector
GB202109069D0 (en) Compounds and method
GB202101107D0 (en) Method of genome editing
EP4100416A4 (en) COMPOSITIONS AND METHODS FOR RAPID RNA ADENYLATION AND RNA SEQUENCING